Stay updated on Pembrolizumab Combo vs Alone in Stage III Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo vs Alone in Stage III Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo vs Alone in Stage III Melanoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed. Notably, the information regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.
    Difference
    0.9%
    Check dated 2025-07-04T02:15:05.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The timeline for the modernization of the ClinicalTrials.gov data ingest has been updated to July 2025, with new registry identifiers and links provided for API users.
    Difference
    2%
    Check dated 2025-06-19T18:15:54.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T08:09:33.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-29T05:44:33.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content or functionality of the page.
    Difference
    0.1%
    Check dated 2025-04-30T13:52:20.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The page has been updated to include new investigational treatments for melanoma, specifically the addition of MK-4830 and Favezelimab + Pembrolizumab, while significant details about the previous study arms and their enrollment status have been removed.
    Difference
    21%
    Check dated 2025-04-16T01:45:06.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo vs Alone in Stage III Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo vs Alone in Stage III Melanoma Clinical Trial page.